Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Acylated piperidine derivatives as melanocortin-4 receptor agonists

Acylated piperidine derivatives as melanocortin-4 receptor agonists

US Patent 7015235 · Granted Mar 21, 2006

Estimated economic value: $67,759,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

GPR40 agonists2025
Compounds for treating or inhibiting recurrence of acute myeloid leukemia2024
Inhibitors of cellular metabolic processes2024
AMPK activators2023
GPR119 agonists2022
Long-acting co-agonists of the glucagon and GLP-1 receptors2022
AMPK activators2022
Inhibitors of cellular metabolic processes2022
AMPK activators2022
Substituted carbapenems for the treatment of bacterial infections2021
Substituted tetrahydroisoquinoline compounds useful as GPR120 agonists2021
Insulin dimer-incretin conjugates2021